Annually, more than 3 billion people are at risk of flavivirus infection, which includes diseases such as yellow fever and dengue fever. In their review, published in npj Viruses, the authors ...

The paper, by J. Hobson-Peters at institution in location; and colleagues was titled, "A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus." ...

As a leading expert in the fields of vaccine development for flaviviruses, his lab undertakes basic research and preclinical development for vaccines against various flavivirus diseases.